U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885970) titled 'The Effect of Cytisine Treatment for Smoking Cessation on Cardiovascular Function in Adult Smokers' on March 13.
Brief Summary: Introduction Pharmacological interventions can enhance smoking cessation success and long-term abstinence. Cytisine, a plant derived alkaloid, is a selective partial agonist at alpha-4 beta-2 nicotinic acetylcholine receptors, which are crucial in nicotine dependence.
Aim of the Study The primary objective of this observational study is to evaluate the efficacy of cytisine in a standard 25-day dosing regimen among adult smokers and users of alternative nicotine products (e-cigarettes or heated tobacco). T...